Compare ECX & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ECX | BME |
|---|---|---|
| Founded | 2017 | 2005 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Trusts Except Educational Religious and Charitable |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 643.6M | 534.8M |
| IPO Year | N/A | N/A |
| Metric | ECX | BME |
|---|---|---|
| Price | $1.74 | $41.51 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.20 | N/A |
| AVG Volume (30 Days) | ★ 3.3M | 34.0K |
| Earning Date | 11-03-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.26% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.44 |
| Revenue | ★ $822,663,229.00 | N/A |
| Revenue This Year | $772.81 | N/A |
| Revenue Next Year | $30.47 | N/A |
| P/E Ratio | ★ N/A | $28.37 |
| Revenue Growth | ★ 6.99 | N/A |
| 52 Week Low | $0.76 | $35.53 |
| 52 Week High | $3.25 | $43.20 |
| Indicator | ECX | BME |
|---|---|---|
| Relative Strength Index (RSI) | 47.20 | 60.82 |
| Support Level | $1.63 | $40.55 |
| Resistance Level | $1.75 | $41.46 |
| Average True Range (ATR) | 0.13 | 0.44 |
| MACD | 0.01 | -0.04 |
| Stochastic Oscillator | 60.76 | 88.04 |
ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services in the People's Republic of China. The company's core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.